Aviad Friedman

This profile gathers the share dealings of Aviad Friedman in Oramed Pharmaceuticals Inc., where the filings describe the role as board member. The record holds 4 filings, for trades running from 9 August 2018 to 3 January 2022.

Purchases make up the whole of the open-market record (2 purchases, €11k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.

The record was last updated on 5 January 2022 with a transaction in Oramed Pharmaceuticals Inc. The last purchase on record was published on 13 August 2018, which is 3,010 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.